Natural regulatory T cells from patients with end-stage renal disease can be used for large-scale generation of highly suppressive alloantigen-specific Tregs

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1203-1213
Number of pages11
JournalKidney International
Volume91
Issue number5
DOIs
Publication statusPublished - 2017

Research programs

  • EMC OR-01

Cite this